- Home
- WASH vs PRME Comparison
WASH vs PRME Comparison
Compare WASH & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WASH | PRME |
|---|---|---|
| Founded | 1800 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 683.9M | 553.2M |
| IPO Year | 1994 | 2022 |
Fundamental Metrics
Financial Performance| Metric | WASH | PRME |
|---|---|---|
| Price | $39.94 | $3.16 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 6 |
| Target Price | ★ $30.25 | $7.56 |
| AVG Volume (30 Days) | 128.0K | ★ 2.6M |
| Earning Date | 04-20-2026 | 05-08-2026 |
| Dividend Yield | ★ 7.22% | N/A |
| EPS Growth | ★ 266.26 | 18.18 |
| EPS | ★ 1.49 | N/A |
| Revenue | ★ $229,048,000.00 | $4,632,000.00 |
| Revenue This Year | N/A | $7.06 |
| Revenue Next Year | $6.19 | $47.01 |
| P/E Ratio | $26.42 | ★ N/A |
| Revenue Growth | ★ 127.57 | 55.28 |
| 52 Week Low | $25.23 | $2.67 |
| 52 Week High | $40.54 | $6.94 |
Technical Indicators
Market Signals| Indicator | WASH | PRME |
|---|---|---|
| Relative Strength Index (RSI) | 55.22 | 47.08 |
| Support Level | $38.43 | $3.16 |
| Resistance Level | $40.20 | $3.69 |
| Average True Range (ATR) | 0.68 | 0.23 |
| MACD | -0.07 | -0.02 |
| Stochastic Oscillator | 66.67 | 21.05 |
Price Performance
Historical ComparisonAbout WASH Washington Trust Bancorp Inc.
Washington Trust Bancorp Inc through its subsidiaries, offers banking and financial services to individuals and businesses. It offers a full range of financial services, including commercial banking, mortgage banking, personal banking, wealth management, and trust services, through its offices located in Rhode Island, Connecticut, and Massachusetts. It operates in two segments. The Commercial Banking segment includes lending activities, commercial loans, residential real estate loan deposit activities, and others. The Wealth Management Services segment consists of investment management, financial planning, personal trust, and estate services, including services as trustee, personal representative, custodian, and guardian, and settlement of decedents' estates.
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company focused on developing a new class of genetic medicines designed to provide durable, and potentially curative, treatment options for patients with diseases driven by defined genetic alterations, acquired cellular dysfunction, or dysregulated gene expression. Its program, PM577 for Wilson Disease, is designed to initially correct the H1069Q mutation in the ATP7B gene and is supported by preclinical data showing targeted correction and restoration of copper homeostasis in animal models. In addition, PM647 is being developed for alpha-1 antitrypsin deficiency, or AATD, another liver targeted disease with substantial unmet need.